Bioartificial lacrimal gland

Patent Citations (4)

Non-Patent Literature (34)

• Casbon et al., “Prolactin inhibits carbachol-dependent secretion by lacrimal acinar cells in vitro,” Adv. Exp. Med. Biol. 506(Pt A):231-235 (2002).Applicant
• Hann et al., “Influence of culture conditions on the androgen control of secretory component production by acinar cells from the rat lacrimal gland,” Invest. Ophthalmol Vis. Sci. 32(9):2610-2621 (1991).Applicant
• Hann et al., “Morphology and function of lacrimal gland acinar cells in primary culture,” Invest Ophthalmol. Vis. Sci. 30(1):145-158 (1989).Applicant
• Huang et al., “Analysis of cytomegalovirus infection and replication in acinar epithelial cells of the rat lacrimal gland,” Invest. Ophthalmol. Vis. Sci. 37(6):1174-1186 (1996).Applicant
• Stevenson et al., “A new model system for studying lacrimal physiology using cultured lacrimal gland acinar cells on Matrigel® rafts,” Adv. Exp. Med. Biol. 506(Pt A):159-163 (2002).Applicant
• Vanaken et al., “Primary rat lacrimal cells undergo acinar-like morphogenesis on reconstituted basement membrane and express secretory component under androgen stimulation,” Exp. Cell. Res. 238(2):377-388 (1998).Applicant
• Yoshino, K., “Establishment of a human lacrimal gland epithelial culture system with in vivo mimicry and its substrate modulation,” Cornea 19(Suppl. 1):S26-S36 (2000).Applicant
• Yoshino, K., “Substrate modulation of morphology, growth, and tear protein production by cultured human lacrimal gland epithelial cells,” Exp. Cell. Res. 220(1):138-151 (1995).Applicant
• Aframian et al., “Absence of tight junction formation in an allogeneic graft cell line used for developing an engineered artificial salivary gland,” Tissue Eng. 8(5):871-878 (2002).Applicant
• Aframian et al., “The growth and morphological behavior of salivary epithelial cells on matrix protein coated biodegradable substrata,” Tissue Eng. 6:209-216 (2000).Applicant
• Agre et al., “The aquaporins, blueprints for cellular plumbing systems,” J. Biol. Chem. 273(24):14659-14662 (1998).Applicant
• Baum, “Principles of saliva secretion,” Ann. NY Acad. Sci. 694:17-23 (1993).Applicant
• Baum, “Prospects for Re-engineering Salivary Glands,” Adv. Dent. Res. 14:84-88 (2000).Applicant
• Cao et al., “Transplantation of chondrocytes utilizing a polymer cell construct to produce tissue-engineered cartilage in the shape of a human ear,” Plast. Reconstr. Surg. 100(2):297-304 (1997).Applicant
• Davis and Vacanti, “Toward development of an implantable tissue engineered liver,” Biomaterials 17 (3):365-372 (1996).Applicant
• Guo et al., “Lacrimal gland epithelial cells stimulate proliferation in autologous lymphocyte preparations,” Exp. Eye. Res. 71(1):11-22 (2000).Applicant
• Johnson and Murphy, “Changes in the tear film and ocular surface from dry eye syndrome,” Prog. Retin. Eye Res. 23(4):449-474 (2004).Applicant
• Kim and Mooney, “Development of biocompatible synthetic extracellular matrices for tissue engineering,” Trends Biotechnol. 16(5):224-230 (1998).Applicant
• Kim et al., “Engineered smooth muscle tissues: regulating cell phenotype with the scaffold,” Exp. Cell Res.: 251(2):318-328 (1999).Applicant
• Kleinman et al., “Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma,” Biochem. 21(24):6188-6193 (1982).Applicant
• Langer and Vacanti, “Tissue engineering,” Science 260(5110):920-926 (1993).Applicant
• Meneray et al. “Morphology and physiologic responsiveness of cultured rabbit lacrimal acini,” Invest. Ophthalmol. Vis. Sci. 35(12):4144-4158 (1994).Applicant
• Mostov et al., “Membrane traffic in polarized epithelial cells,” Curr. Opin. Cell Biol. 12(4):483-490 (2000).Applicant
• Nerem and Sambanis, “Tissue engineering: From biology to biological substitutes,” Tissue Engineering 1(1):3-13 (1995).Applicant
• Nguyen et al., “Characterization of immortalized rabbit lacrimal gland epithelial cells,” In Vitro Cell Dev. Biol. Anim. 35(4):198-204 (1999).Applicant
• Oberpenning et al., “De novo reconstitution of functional mammalian urinay bladder by tissue engineering,” Nat. Biotechnol. 17:149-155 (1999).Applicant
• Pastan and Bailey, “Dialysis therapy,” New Engl. J. Med. 338(20):1428-1437 (1998).Applicant
• Saarloos et al., “Intermediate filament, laminin and integrin expression in lacrimal gland acinar cells: Comparison of an immortalized cell line to primary cells, and their response to retinoic acid,” Curr. Eye Res. 19(5):439-449 (1999).Applicant
• Schaumberg et al., “Epidemiology of dry eye syndrome,” Adv. Exp. Med. Biol. 506 (Part B):989-998 (2002).Applicant
• Schechter et al., “Growth of purified lacrimal acinar cells in matrigel raft cultures,” Exp. Eye Res. 74:349-360 (2002).Applicant
• Schonthal et al., “Proliferation of lacrimal gland acinar cells in primary culture. Stimulation by extracellular matrix, EGF, and DHT,” Exp Eye Res. 70(5):639-649 (2000).Applicant
• Sheridan et al., “Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth delivery,” J. Control. Rel. 64:91-102 (2000).Applicant
• Smith, Slide presentation at the American Academy of Ophthalmology 2003 Annual Meeting, Nov. 17, 2003.Applicant
• Tsubota, “Understanding dry eye syndrome. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3 Basic Science and Clinical Relevance,” Adv. Exp. Med. Biol. 506 (Part A):3-16 (2002).Applicant